190 related articles for article (PubMed ID: 28617959)
21. Development of an alcohol deprivation and escalation effect in C57BL/6J mice.
Melendez RI; Middaugh LD; Kalivas PW
Alcohol Clin Exp Res; 2006 Dec; 30(12):2017-25. PubMed ID: 17117967
[TBL] [Abstract][Full Text] [Related]
22. The administration of Alda-1, an activator of ALDH2, inhibits relapse-like ethanol intake in female alcohol-preferring UChB rats.
Quilaqueo ME; Adasme S; Solís-Egaña F; Quintanilla ME; Vásquez D; Morales P; Herrera-Marschitz M; Rivera-Meza M
Life Sci; 2023 Sep; 328():121876. PubMed ID: 37348813
[TBL] [Abstract][Full Text] [Related]
23. Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats.
Scuppa G; Cippitelli A; Toll L; Ciccocioppo R; Ubaldi M
Drug Alcohol Depend; 2015 Nov; 156():126-132. PubMed ID: 26383997
[TBL] [Abstract][Full Text] [Related]
24. Effects of repeated alcohol deprivations on operant ethanol self-administration by alcohol-preferring (P) rats.
Rodd ZA; Bell RL; Kuc KA; Murphy JM; Lumeng L; Li TK; McBride WJ
Neuropsychopharmacology; 2003 Sep; 28(9):1614-21. PubMed ID: 12799615
[TBL] [Abstract][Full Text] [Related]
25. An improved model of ethanol and nicotine co-use in female P rats: Effects of naltrexone, varenicline, and the selective nicotinic α6β2* antagonist r-bPiDI.
Maggio SE; Saunders MA; Nixon K; Prendergast MA; Zheng G; Crooks PA; Dwoskin LP; Bell RL; Bardo MT
Drug Alcohol Depend; 2018 Dec; 193():154-161. PubMed ID: 30384323
[TBL] [Abstract][Full Text] [Related]
26. Effects of ethanol, naltrexone, nicotine and varenicline in an ethanol and nicotine co-use model in Sprague-Dawley rats.
Chandler CM; Maggio SE; Peng H; Nixon K; Bardo MT
Drug Alcohol Depend; 2020 Jul; 212():107988. PubMed ID: 32387915
[TBL] [Abstract][Full Text] [Related]
27. Effects of multiple alcohol deprivations on operant ethanol self-administration by high-alcohol-drinking replicate rat lines.
Oster SM; Toalston JE; Kuc KA; Pommer TJ; Murphy JM; Lumeng L; Bell RL; McBride WJ; Rodd ZA
Alcohol; 2006 Apr; 38(3):155-64. PubMed ID: 16905441
[TBL] [Abstract][Full Text] [Related]
28. Prazosin Prevents Increased Anxiety Behavior That Occurs in Response to Stress During Alcohol Deprivations.
Rasmussen DD; Kincaid CL; Froehlich JC
Alcohol Alcohol; 2017 Jan; 52(1):5-11. PubMed ID: 27797712
[TBL] [Abstract][Full Text] [Related]
29. Effects of concurrent access to multiple ethanol concentrations and repeated deprivations on alcohol intake of alcohol-preferring rats.
Rodd-Henricks ZA; Bell RL; Kuc KA; Murphy JM; McBride WJ; Lumeng L; Li TK
Alcohol Clin Exp Res; 2001 Aug; 25(8):1140-50. PubMed ID: 11505045
[TBL] [Abstract][Full Text] [Related]
30. Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents.
McBride WJ; Li TK
Crit Rev Neurobiol; 1998; 12(4):339-69. PubMed ID: 10348615
[TBL] [Abstract][Full Text] [Related]
31. Role of GABA(B) receptor in alcohol dependence: reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics.
Colombo G; Addolorato G; Agabio R; Carai MA; Pibiri F; Serra S; Vacca G; Gessa GL
Neurotox Res; 2004; 6(5):403-14. PubMed ID: 15545024
[TBL] [Abstract][Full Text] [Related]
32. Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers.
Lim AC; Roche DJO; Ray LA
J Stud Alcohol Drugs; 2018 Nov; 79(6):918-928. PubMed ID: 30573023
[TBL] [Abstract][Full Text] [Related]
33. The expression of an alcohol deprivation effect in the high-alcohol-drinking replicate rat lines is dependent on repeated deprivations.
Rodd-Henricks ZA; McKinzie DL; Murphy JM; McBride WJ; Lumeng L; Li TK
Alcohol Clin Exp Res; 2000 Jun; 24(6):747-53. PubMed ID: 10888060
[TBL] [Abstract][Full Text] [Related]
34. The selective κ-opioid receptor antagonist JDTic attenuates the alcohol deprivation effect in rats.
Uhari-Väänänen J; Eteläinen T; Bäckström P; Oinio V; Carroll FI; Raasmaja A; Kiianmaa K; Piepponen P
Eur Neuropsychopharmacol; 2019 Dec; 29(12):1386-1396. PubMed ID: 31679889
[TBL] [Abstract][Full Text] [Related]
35. Effects of concurrent access to multiple ethanol concentrations and repeated deprivations on alcohol intake of high-alcohol-drinking (HAD) rats.
Rodd ZA; Bell RL; Kuc KA; Murphy JM; Lumeng L; McBride WJ
Addict Biol; 2009 Apr; 14(2):152-64. PubMed ID: 19076927
[TBL] [Abstract][Full Text] [Related]
36. Effects of long-term episodic access to ethanol on the expression of an alcohol deprivation effect in low alcohol-consuming rats.
Bell RL; Rodd ZA; Boutwell CL; Hsu CC; Lumeng L; Murphy JM; Li TK; McBride WJ
Alcohol Clin Exp Res; 2004 Dec; 28(12):1867-74. PubMed ID: 15608603
[TBL] [Abstract][Full Text] [Related]
37. Neuropeptide Y (NPY)-induced reductions in alcohol intake during continuous access and following alcohol deprivation are not altered by restraint stress in alcohol-preferring (P) rats.
Bertholomey ML; Henderson AN; Badia-Elder NE; Stewart RB
Pharmacol Biochem Behav; 2011 Jan; 97(3):453-61. PubMed ID: 20937300
[TBL] [Abstract][Full Text] [Related]
38. The α2-adrenergic receptor agonist, clonidine, reduces alcohol drinking in alcohol-preferring (P) rats.
Rasmussen DD; Alexander L; Malone J; Federoff D; Froehlich JC
Alcohol; 2014 Sep; 48(6):543-9. PubMed ID: 25085719
[TBL] [Abstract][Full Text] [Related]
39. The Effects of Long-Term Varenicline Administration on Ethanol and Sucrose Seeking and Self-Administration in Male P Rats.
Czachowski CL; Froehlich JC; DeLory M
Alcohol Clin Exp Res; 2018 Feb; 42(2):453-460. PubMed ID: 29168193
[TBL] [Abstract][Full Text] [Related]
40. The neuropeptide-Y Y5 receptor antagonist L-152,804 decreases alcohol self-administration in inbred alcohol-preferring (iP) rats.
Schroeder JP; Overstreet DH; Hodge CW
Alcohol; 2005 Jul; 36(3):179-86. PubMed ID: 16377459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
